Background: The clinical significance of uric acid (UA) in patients with chronic kidney disease (CKD) has never been elucidated in detail. Objectives: The aim of this study was to elucidate the predictive value of hyperuricemia (HU) in relation to kidney disease progression in CKD patients. Methods: We reviewed data obtained from 201 CKD patients. Renal outcome was assessed by performing the Kaplan-Meier and Cox proportional hazard regression models. The renal outcomes of CKD patients with and without HU were compared by using a propensity score-matched cohort. Results: The results of a multivariate Cox regression analysis showed that HU (UA ≥ 7.1 mg/dL) ( P = 0.001), diabetes mellitus ( P = 0.003), and a high urine albumin-to-creatinine ratio ( P = 0.0005) were significantly associated with a ≥50% eGFR decline or ESRD. The serum UA values were positively correlated with mean blood pressure ( P = 0.007), visceral fat area ( P = 0.0003), and maximum carotid intima-media thickness ( P = 0.0003). The Kaplan-Meier analysis in the propensity score-matched cohort indicated that the renal survival rate of the group of CKD patients with HU was significantly lower than that of the group without HU (log rank, P < 0.0001), even after complete adjustment for the eGFR. Conclusion: The results of this study suggest that the serum UA value is a predictor of CKD progression.
Nenov, V.D., Taal, M.W., Sakharova, O.V. and Brenner, B.M. (2000) Multi-Hit Nature of Chronic Renal Disease. Current Opinion in Nephrology and Hypertension, 29, 85-97. https://doi.org/10.1097/00041552-200003000-00001
Taal, M.W. and Brenner, B.M. (2006) Predicting Initiation and Progression of Chronic Kidney Disease: Developing Renal Risk Scores. Kidney International, 70, 1694-1705. https://doi.org/10.1038/sj.ki.5001794
Goicoechea, M., Garcia de Vinuesa, S., Verdalles, U., Verde, E., Macias, N., et al. (2015) Allopurinol and Progression of CKD and Cardiovascular Events: Long-Term Follow-Up of a Randomized Clinical Trial. American Journal of Kidney Diseases, 65, 543-549. https://doi.org/10.1053/j.ajkd.2014.11.016
Momoki, K., Kataoka, H., Moriyama, T., Mochizuki, T. and Nitta, K. (2016) Hyperuricemia as a Predictive Marker for Progression of Nephrosclerosis: Clinical Assessment of Prognostic Factors in Biopsy-Proven Arterial/Arteriolar Nephrosclerosis. Journal of Atherosclerosis and Thrombosis.
Dousdampanis, P., Trigka, K., Musso, C.G. and Fourtounas, C. (2014) Hyperuricemia and Chronic Kidney Disease: An Enigma Yet to Be Solved. Renal Failure, 36, 1351-1359. https://doi.org/10.3109/0886022X.2014.947516
Giordano, C., Karasik, O., King-Morris, K. and Asmar, A. (2015) Uric Acid as a Marker of Kidney Disease: Review of the Current Literature. Disease Markers, 2015, 382918. https://doi.org/10.1155/2015/382918
Borghi, C., Rosei, E.A., Bardin, T., Dawson, J., Dominiczak, A., Kielstein, J.T., et al. (2015) Serum Uric Acid and the Risk of Cardiovascular and Renal Disease. Journal of Hypertension, 33, 1729-1741. https://doi.org/10.1097/HJH.0000000000000701
Nacak, H., van Diepen, M., Qureshi, A.R., Carrero, J.J., Stijnen, T., et al. (2015) Uric Acid is Not Associated with Decline in Renal Function or Time to Renal Replacement Therapy Initiation in a Referred Cohort of Patients with Stage III, IV and V Chronic Kidney Disease. Nephrology Dialysis Transplantation, 30, 2039-2045. https://doi.org/10.1093/ndt/gfv225
Uchida, S., Chang, W.X., Ota, T., Tamura, Y., Shiraishi, T., Kumagai, T., et al. (2015) Targeting Uric Acid and the Inhibition of Progression to End-Stage Renal Disease—A Propensity Score Analysis. PLoS One, 10, e0145506. https://doi.org/10.1371/journal.pone.0145506
Iseki, K., Ikemiya, Y., Inoue, T., Iseki, C., Kinjo, K. and Takishita, S. (2004) Significance of Hyperuricemia as a Risk Factor for Developing ESRD in a Screened Cohort. American Journal of Kidney Diseases, 44, 642-650. https://doi.org/10.1016/S0272-6386(04)00934-5
Madero, M., Sarnak, M.J., Wang, X., Greene, T., Beck, G.J., Kusek, J.W., et al. (2009) Uric Acid and Long-Term Outcomes in CKD. American Journal of Kidney Diseases, 53, 796-803. https://doi.org/10.1053/j.ajkd.2008.12.021
Takahashi, S., Yamamoto, T., Tsutsumi, Z., Moriwaki, Y., Yamakita, J. and Higashino, K. (1997) Close Correlation between Visceral fat Accumulation and Uric Acid Metabolism in Healthy Men. Metabolism, 6, 1162-1165.
Kanbay, M., Jensen, T., Solak, Y., Le, M., Roncal-Jimenez, C., Rivard, C., et al. (2016) Uric Acid in Metabolic Syndrome: From an Innocent Bystander to a Central Player. European Journal of Internal Medicine, 29, 3-8.
Ishizaka, N., Ishizaka, Y., Toda, E., Nagai, R. and Yamakado, M. (2005) Association between Serum Uric Acid, Metabolic Syndrome, and Carotid Atherosclerosis in Japanese Individuals. Arteriosclerosis, Thrombosis, and Vascular Biology, 25, 1038-1044. https://doi.org/10.1161/01.ATV.0000161274.87407.26
Levey, A.S., Eckardt, K.U., Tsukamoto, Y., Levin, A., Coresh, J., Rossert, J., et al. (2005) Definition and Classification of Chronic Kidney Disease: A Position Statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney International, 67, 2089-2100. https://doi.org/10.1111/j.1523-1755.2005.00365.x
Matsuo, S., Imai, E., Horio, M., Yasuda, Y., Tomita, K., Nitta, K., et al. (2009) Revised Equations for Estimated GFR from Serum Creatinine in Japan. American Journal of Kidney Diseases, 53, 982-992. https://doi.org/10.1053/j.ajkd.2008.12.034
Spooner, R.J., Weir, R.J. and Frier, B.M. (1987) Detection of Microalbuminuria in Diabetic Patients Using a Simple Latex Agglutination Test. Clinica Chimica Acta, 166, 247-253.
Lash, T.L., Mor, V., Wieland, D., Ferrucci, L., Satariano, W. and Silliman, R.A. (2007) Methodology, Design, and Analytic Techniques to Address Measurement of Comorbid Disease. Journal of Gerontology Series A: Biological Sciences and Medical Sciences, 62, 281-285. https://doi.org/10.1093/gerona/62.3.281
Ording, A.G. and Sorensen, H.T. (2013) Concepts of Comorbidities, Multiple Morbidities, Complications, and Their Clinical Epidemiologic Analogs. Clinical Epidemiology, 5, 199-203. https://doi.org/10.2147/CLEP.S45305
Borkan, G.A., Gerzof, S.G., Robbins, A.H., Hults, D.E., Silbert, C.K. and Silbert, J.E. (1982) Assessment of Abdominal Fat Content by Computed Tomography. American Journal of Clinical Nutrition, 36, 172-177.
Grauer, W.O., Moss, A.A., Cann, C.E. and Goldberg, H.I. (1984) Quantification of Body Fat Distribution in the Abdomen Using Computed Tomography. American Journal of Clinical Nutrition, 39, 631-637.
De Bray, J.M., Baud, J.M., Delanoy, P., Camuzat, J.P., Dehans, V., Descamp-Le Chevoir, J., et al. (1998) Reproducibility in Ultrasonic Characterization of Carotid Plaques. Cerebrovascular Diseases, 8, 273-277. https://doi.org/10.1159/000015865
Liang, M.H. and Fries, J.F. (1978) Asymptomatic Hyperuricemia: The Case for Conservative Management. Annals of Internal Medicine, 88, 666-670. https://doi.org/10.7326/0003-4819-88-5-666
Bose, B., Badve, S.V., Hiremath, S.S., Boudville, N., Brown, F.G., Cass, A., et al. (2014) Effects of Uric Acid-Lowering Therapy on Renal Outcomes: A Systematic Review and Meta-Analysis. Nephrology Dialysis Transplantation, 29, 406-413. https://doi.org/10.1093/ndt/gft378
Weiner, D.E., Tighiouart, H., Elsayed, E.F., Griffith, J.L., Salem, D.N. and Levey, A.S. (2008) Uric Acid and Incident Kidney Disease in the Community. Journal of American Society of Nephrology, 19, 1204-1211. https://doi.org/10.1681/ASN.2007101075
Bellomo, G., Venanzi, S., Verdura, C., Saronio, P., Esposito, A. and Timio, M. (2010) Association of Uric Acid with Change in Kidney Function in Healthy Normotensive Individuals. American Journal of Kidney Diseases, 56, 264-272. https://doi.org/10.1053/j.ajkd.2010.01.019
Zoppini, G., Targher, G., Chonchol, M., Ortalda, V., Abaterusso, C., Pichiri, I., et al. (2012) Serum Uric Acid Levels and Incident Chronic Kidney Disease in Patients with Type 2 Diabetes and Preserved Kidney Function. Diabetes Care, 35, 99-104. https://doi.org/10.2337/dc11-1346
Ficociello, L.H., Rosolowsky, E.T., Niewczas, M.A., Maselli, N.J., Weinberg, J.M, Aschengrau, A., et al. (2010) High-Normal Serum Uric Acid Increases Risk of Early Progressive Renal Function Loss in Type 1 Diabetes: Results of a 6-Year Follow-Up. Diabetes Care, 33, 1337-1343. https://doi.org/10.2337/dc10-0227
Ohno, I., Hosoya, T., Gomi, H., Ichida, K., Okabe, H. and Hikita, M. (2001) Serum Uric Acid and Renal Prognosis in Patients with IgA Nephropathy. Nephron, 87, 333-339. https://doi.org/10.1159/000045939
Syrjanen, J., Mustonen, J. and Pasternack, A. (2000) Hypertriglyceridaemia and Hyperuricaemia Are Risk Factors for Progression of IgA Nephropathy. Nephrology Dialysis Transplantation, 5, 34-42. https://doi.org/10.1093/ndt/15.1.34
Wu, J., Chen, X., Xie, Y., Yamanaka, N., Shi, S., Wu, D., et al. (2005) Characteristics and Risk Factors of Intrarenal Arterial Lesions in Patients with IgA Nephropathy. Nephrology Dialysis Transplantation, 20, 719-727. https://doi.org/10.1093/ndt/gfh716
Moriyama, T., Itabashi, M., Takei, T., Kataoka, H., Sato, M., Shimizu, A., et al. (2015) High Uric Acid Level Is a Risk Factor for Progression of IgA Nephropathy with Chronic Kidney Disease Stage G3a. Journal of Nephrology, 28, 451-456. https://doi.org/10.1007/s40620-014-0154-0
Akalin, E., Ganeshan, S.V., Winston, J. and Muntner, P. (2008) Hyperuricemia Is Associated with the Development of the Composite Outcomes of New Cardiovascular Events and Chronic Allograft Nephropathy. Transplantation, 86, 652-658. https://doi.org/10.1097/TP.0b013e3181814f5b
Takayama, S., Kawamoto, R., Kusunoki, T., Abe, M. and Onji, M. (2012) Uric Acid Is an Independent Risk Factor for Carotid Atherosclerosis in a Japanese Elderly Population without Metabolic Syndrome. Cardiovascular Diabetology, 11, 2. https://doi.org/10.1186/1475-2840-11-2
Taniguchi, Y., Hayashi, T., Tsumura, K., Endo, G., Fujii, S. and Okada, K. (2001) Serum Uric Acid and the Risk for Hypertension and Type 2 Diabetes in Japanese Men: The Osaka Health Survey. Journal of Hypertension, 19, 1209-1215. https://doi.org/10.1097/00004872-200107000-00005
Guo, M., Niu, J.Y., Li, S.R., Ye, X.W., Fang, H., Zhao, Y.P., et al. (2015) Gender Differences in the Association between Hyperuricemia and Diabetic Kidney Disease in Community Elderly Patients. Journal of Diabetes Complications, 29, 1042-1049.
Fessel, W.J. (1979) Renal Outcomes of Gout and Hyperuricemia. American Journal of Medicine, 67, 74-82.
Baldwin, W., McRae, S., Marek, G., Wymer, D., Pannu, V., Baylis, C., et al. (2011) Hyperuricemia as a Mediator of the Proinflammatory Endocrine Imbalance in the Adipose Tissue in a Murine Model of the Metabolic Syndrome. Diabetes, 60, 1258-1269. https://doi.org/10.2337/db10-0916
Tsushima, Y., Nishizawa, H., Tochino, Y., Nakatsuji, H., Sekimoto, R., Nagao, H., et al. (2013) Uric Acid Secretion from Adipose Tissue and Its Increase in Obesity. Journal of Biological Chemistry, 288, 27138-27149. https://doi.org/10.1074/jbc.M113.485094
Yamada, A., Sato, K.K., Kinuhata, S., Uehara, S., Endo, G., Hikita, Y., et al. (2016) Association of Visceral Fat and Liver Fat with Hyperuricemia. Arthritis Care and Research, 68, 553-561. https://doi.org/10.1002/acr.22729
Matsuura, F., Yamashita, S., Nakamura, T., Nishida, M., Nozaki, S., Funahashi, T., et al. (1998) Effect of Visceral Fat Accumulation on Uric Acid Metabolism in Male Obese Subjects: Visceral Fat Obesity Is Linked More Closely to Overproduction of Uric Acid than Subcutaneous Fat Obesity. Metabolism, 47, 929-933.
Nakagawa, T., Hu, H., Zharikov, S., Tuttle, K.R., Short, R.A., Glushakova, O., et al. (2006) A Causal Role for Uric Acid in Fructose-Induced Metabolic Syndrome. American Journal of Physiology Renal Physiology, 290, F625-F631. https://doi.org/10.1152/ajprenal.00140.2005
Kataoka, H., Ariyama, Y., Deushi, M., Osaka, M., Nitta, K. and Yoshida, M. (2016) Inhibitory Effect of Serotonin Antagonist on Leukocyte-Endothelial Interactions in Vivo and in Vitro. PLoS ONE, 11, e0147929. https://doi.org/10.1371/journal.pone.0147929
Sanchez-Lozada, L.G., Lanaspa, M.A., Cristobal-Garcia, M., Garcia-Arroyo, F., Soto, V., Cruz-Robles, D., et al. (2012) Uric Acid-Induced Endothelial Dysfunction Is Associated with Mitochondrial Alterations and Decreased Intracellular ATP Concentrations. Nephron Experimental Nephrology, 121, e71-e78. https://doi.org/10.1159/000345509
Corry, D.B., Eslami, P., Yamamoto, K., Nyby, M.D., Makino, H. and Tuck, M.L. (2008) Uric Acid Stimulates Vascular Smooth Muscle Cell Proliferation and Oxidative Stress via the Vascular Renin-Angiotensin System. Journal of Hypertension, 26, 269-275. https://doi.org/10.1097/HJH.0b013e3282f240bf
Kanellis, J., Watanabe, S., Li, J.H., Kang, D.H., Li, P., Nakagawa, T., et al. (2003) Uric Acid Stimulates Monocyte Chemoattractant Protein-1 Production in Vascular Smooth Muscle Cells via Mitogen-Activated Protein Kinase and Cyclooxygenase-2. Hypertension, 41, 1287-1293. https://doi.org/10.1161/01.HYP.0000072820.07472.3B
Mazzali, M., Hughes, J., Kim, Y.G., Jefferson, J.A., Kang, D.H., Gordon, K.L., et al. (2001) Elevated Uric Acid Increases Blood Pressure in the Rat by a Novel Crystal-Independent Mechanism. Hypertension, 38, 1101-1106. https://doi.org/10.1161/hy1101.092839
Nakagawa, T., Mazzali, M., Kang, D.H., Kanellis, J., Watanabe, S., Sanchez-Lozada, L.G., et al. (2003) Hyperuricemia Causes Glomerular Hypertrophy in the Rat. American Journal of Nephrology, 23, 2-7. https://doi.org/10.1159/000066303
Kojima, C., Takei, T., Ogawa, T. and Nitta, K. (2012) Serum Complement C3 Predicts Renal Arteriolosclerosis in Non-Diabetic Chronic Kidney Disease. Journal of Atherosclerosis Thrombosis, 19, 854-861. https://doi.org/10.5551/jat.12286
Kohagura, K., Kochi, M., Miyagi, T., Kinjyo, T., Maehara, Y., Nagahama, K., et al. (2013) An Association between Uric Acid Levels and Renal Arteriolopathy in Chronic Kidney Disease: A Biopsy-Based Study. Hypertension Research, 36, 43-49. https://doi.org/10.1038/hr.2012.135